Lung cancer cells with high ALDH1 activity treated with ATRA decreased ALDH1A1 protein levels without affecting mRNA levels, resulting in sensitization to 4-hydroperoxycyclophosphamide25. Here, ALDH1A1 is linked to lung cancer.